Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 14, 2020 01:27PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
StockWatch lists ZHCLF as having shares outstanding 134.99M.
ZHCLF SPP $0.39 US. and Volume: 33.65K
https://www.marketwatch.com/investing/stock/zhclf
ZCC (Calgary) MD&A shows shares outstanding 134,990,827.
Head scratcher, to say the least.
Koo